Search results
Lexaria (NASDAQ: LEXX) to Validate Earlier Semaglutide Studies with Successful GLP-1-H24-2 Study...
Digital Journal· 12 hours agoLexaria's patented DehydraTECH(TM) "drug delivery platform technology" increases bioavailability, improving the way...
Lexaria (NASDAQ: LEXX) Announces Noteworthy Findings from Interim Results of Ongoing Diabetes Animal...
Digital Journal· 4 days agoPRESS RELEASE Published July 19, 2024 InvestorBrandNetwork Lexaria Bioscience (NASDAQ: LEXX, LEXXW) , a global innovator in drug delivery platforms, today announced the receipt ...
How to Explore a Praise Kink If You’re Seriously Turned On by Validation
Self via Yahoo News· 5 days agoPlenty of people enjoy praise, but it can feel especially good to receive it for sex stuff—“skills...
Positive Interim Body Weight Results from Lexaria's Diabetes Animal Study
Digital Journal· 7 days agoKELOWNA, BC / ACCESSWIRE / July 17, 2024 / Lexaria Bioscience Corp. (Nasdaq:LEXX, LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces ...
SuperCom (NASDAQ: SPCB) Wins New Contract to Provide Rehabilitative Services to Juveniles
Digital Journal· 4 days ago...19:37 InvestorBrandNetwork More from InvestorBrandNetwork SuperCom (NASDAQ: SPCB) Secures Contract for Juvenile Monitoring Lexaria (NASDAQ: LEXX) Reports Issuance of Three New Patents Clene (NASDAQ: CLNN) to Present at the 73rd Emerging Growth Conference Annovis Bio (NYSE...